Different ATR inhibitors, such as M4344, Camonsertib, AZD6738 (Ceralasertib), and BAY1895344, are now in clinical trials for solid tumors, with the potential to also be tested in MM. The gene discussed is ATR; the disease is Miyoshi myopathy.